Long-term entecavir (ETV) therapy improves liver stiffness measurements (LSMs) in patients with HBeAg-negative chronic hepatitis B (CHB)

被引：0
|
作者：
Papatheodoridis, George V. [1 ]
Goulis, Ioannis [2 ]
Manolakopoulos, Spilios [1 ]
Margariti, Katerina [1 ]
Exarchos, Xenofon [2 ]
Kokkonis, George [2 ]
Papaioannou, Christos [1 ]
Akriviadis, Evangelos A. [2 ]
机构：
[1] Hippokrateion Hosp, Dept Internal Med 2, Athens, Greece
[2] Aristotle Univ Thessaloniki, Dept Med 4, Hippokrat Gen Hosp, GR-54006 Thessaloniki, Greece
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
384
引用
收藏
页码：380A / 380A
页数：1
相关论文
共 50 条
  • [21] Progress in HBeAg-negative chronic hepatitis B therapy
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 (1): : 11 - 11
  • [22] Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
    Manolakopoulos, Spilios
    Striki, Athanasia
    Deutsch, Melanie
    Mela, Maria
    Ketikoglou, Ioannis
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2011, 31 (10) : 1525 - 1532
  • [23] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [24] NONCOMPLIANCE, ANTIVIRAL RESISTANCE, AND VIROLOGIC RESPONSE (VR) IN TREATMENT-NAiVE HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) ON LONG-TERM THERAPY WITH ENTECAVIR 0.5 MG (ETV) OR ADEFOVIR 10 MG (ADV) IN A REAL-LIFE CLINICAL SETTING
    Ha, Nghiem B.
    Ha, Nghi B.
    Garcia, Ruel T.
    Trinh, Huy N.
    Nguyen, Khanh K.
    Nguyen, Huy A.
    Levitt, Brian S.
    Vu, Andrew A.
    Nguyen, Mindie H.
    HEPATOLOGY, 2009, 50 (04) : 513A - 513A
  • [25] Hepatitis B virus relapse after discontinuation of long-term treatment with tenofovir in chronic HBeAg-negative patients
    Buti, Maria
    Homs, Maria
    Casillas, Rosario
    Tabernero, David
    Gregori, Josep
    Gonzalez, Carolina
    Riveiro-Barciela, Mar
    Teresa Salcedo, Maria
    Blasi, Maria
    Nieto, Leonardo
    Rodriguez-Frias, Francisco
    Esteban, Rafael
    HEPATOLOGY, 2014, 60 : 1032A - 1032A
  • [26] Long-term follow-up of treatment-naive HBeAg-negative patients with chronic hepatitis B
    Ozdemir, Yusuf Emre
    Ozdemir, Meryem Sahin
    Bayramlar, Osman Faruk
    Surme, Serkan
    Kaya, Sibel Yildiz
    Karaali, Ridvan
    Balkan, Ilker Inanc
    Mete, Bilgul
    Saltoglu, Nese
    Tabak, Fehmi
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 633 - 639
  • [27] Management of patients with HBeAg-negative chronic hepatitis B
    Saikia, Nripen
    Talukdar, Rupjyoti
    Mazumder, Subhasish
    Khanna, Sudeep
    Tandon, Rakesh
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (975) : 32 - 39
  • [28] Long-term antiviral therapy with lamivudine (LAM) and salvage adefovir dipivoxil (ADV) improves the outcome of patients with HBeAg-NEGATIVE chronic hepatitis B (CHBe-)
    Papatheodoridis, GV
    Dimou, E
    Dimakopoulos, K
    Manolakopoulos, S
    Rapti, I
    Kitis, G
    Tzourmakliotis, D
    Manesis, E
    Hadziyannis, SJ
    JOURNAL OF HEPATOLOGY, 2005, 42 : 189 - 189
  • [29] The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore
    Lacey, L. F.
    Gane, E.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (11) : 751 - 766
  • [30] Efficacy of long-term lamivudine therapy in HBeAg negative chronic hepatitis B
    Dimou, E
    Papatheodoridis, GC
    Laras, A
    Rapti, I
    Dourakis, S
    Hadziyannis, SJ
    HEPATOLOGY, 1999, 30 (04) : 646A - 646A
12345